We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Electronic Implant Replaces Impaired Middle Ear

By HospiMedica International staff writers
Posted on 30 Jan 2013
Functionally deaf patients can gain normal hearing with a new bone anchored hearing aid (BAHA) implant that uses bone conduction to transmit sound vibrations to the inner ear. More...


Developed by researchers at Chalmers University of Technology (Gothenburg, Sweden) and Sahlgrenska University Hospital (Gothenburg, Sweden), the Bone Conduction Implant (BCI) BAHA has been designed to treat mechanical hearing loss in individuals who have been affected by chronic inflammation of the outer or middle ear, bone disease, or who have congenital malformations of the outer ear, auditory canal, or middle ear. The BCI does not need to be anchored to the skull bone using a titanium screw through the skin, as do current bone-conduction devices.

The device comprises two parts: one exterior processor and one implant, slightly less than six cm long, which is inserted just behind the ear, under the skin, into the bone itself. A coil placed at the upper end uses magnetic induction to couple with the outer, visible component, an external sound processor held in place with two magnets that the patient can easily remove and attach from the head. The inductive link transmits sound from the patient's surroundings through to an internal receiver, with the audio signal transmitted to a tiny quadratic loudspeaker anchored to the bone near the auditory canal. The speaker generates sound vibrations, which reach the sensory organs of the cochlea.

“The implant will be very comfortable and aesthetically attractive. Because the implant is securely fixed under the skin, the patient won't need to be more careful than other people during, for example, outdoor activities, and water sports,” said Prof. Bo Håkansson, PhD, of the department of signals and systems at Chalmers.” You hear 50% of your own voice through bone conduction, so you perceive this sound as quite natural.”

“Earlier tests indicate that the volume may be around 5 decibels higher and the quality of sound at high frequencies will be better with BCI than with previous bone-anchored techniques,” added Måns Eeg-Olofsson, MD, who implanted the first device in December 2012. “Now it's time to activate the first patient's implant, and adapt it to the patient's hearing and wishes. Then hearing tests and checks will be performed roughly every three months until a year after the operation. At that point, we will end the process with a final X-ray examination and final hearing tests. If we get good early indications we will continue operating other patients during this spring already.”

Related Links:

Chalmers University of Technology
Sahlgrenska University Hospital



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.